Brain accumulation of the EML4-ALK inhibitor ceritinib is restricted by P-glycoprotein (P-GP/ABCB1) and breast cancer resistance protein (BCRP/ABCG2)

出版年份 2015 全文链接

标题

作者

关键词

Ceritinib, ALK inhibitor, ABCB1, ABCG2, Blood-brain barrier, Oral availability

出版物

Volume 102, Issue -, Pages 200-207

出版商

Elsevier BV

发表日期

2015-09-09

DOI

10.1016/j.phrs.2015.09.003

联系作者

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Discuss science. Find collaborators. Network.

Join a conversation